Portfolio
HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.
Overview as at 30 June 2026
Currency allocation of assets
Emphasis on US dollar investments
56
340
US dollar (USD)
68
Euro (EUR)
9
Renminbi (CNY)
8
Swiss franc (CHF)
7
Indian rupee (INR)
5
Other currencies (CAD, DKK, GBP, HDK, SEK)
3
#619359
#3e5a9a
#f18825
#b94513
#edc500
#8aacb4
#8c74af
#00a4c8
#cab415
#423e3d
Allocation of assets
Mainly invested in private companies or in companies originating
from the private companies portfolio.
62
340
Private companies
25
Public (from private) companies
21
Public companies
31
Funds
7
Cash and cash equivalents
12
Other assets
4
#619359
#3e5a9a
#f18825
#b94513
#edc500
#8aacb4
#8c74af
#00a4c8
#cab415
#423e3d
Development phase of portfolio companies
Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.
69
90
Profitable
37
Products on the market
13
Phase I
6
Phase II
25
Phase III
17
Preclinical
2
#619359
#3e5a9a
#f18825
#b94513
#edc500
#8aacb4
#8c74af
#00a4c8
#cab415
#423e3d
Therapeutic area of the lead product of portfolio companies
Broadly diversified areas of activity.
79
350
Oncology
30
Others
21
Central nervous system
13
Immunology/Inflammation
13
Synthetic biology
9
Orphan diseases
6
Medical technology / diagnostics
5
Digital Health
3
#619359
#3e5a9a
#f18825
#b94513
#edc500
#8aacb4
#8c74af
#00a4c8
#cab415
#423e3d